Symptomatic benefits of testosterone treatment in patient subgroups : a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis
| dc.contributor.author | Hudson, Jemma | |
| dc.contributor.author | Cruickshank, Moira | |
| dc.contributor.author | Quinton, Richard | |
| dc.contributor.author | Aucott, Lorna | |
| dc.contributor.author | Wu, Frederick | |
| dc.contributor.author | Grossmann, Mathis | |
| dc.contributor.author | Bhasin, Shalender | |
| dc.contributor.author | Snyder, Peter J | |
| dc.contributor.author | Ellenberg, Susan S | |
| dc.contributor.author | Travison, Thomas G | |
| dc.contributor.author | Brock, Gerald B | |
| dc.contributor.author | Gianatti, Emily J | |
| dc.contributor.author | van der Schouw, Yvonne T | |
| dc.contributor.author | Emmelot-Vonk, Marielle H | |
| dc.contributor.author | Giltay, Erik J | |
| dc.contributor.author | Hackett, Geoff | |
| dc.contributor.author | Ramachandran, Sudarshan | |
| dc.contributor.author | Svartberg, Johan | |
| dc.contributor.author | Hildreth, Kerry L | |
| dc.contributor.author | Antonic, Kristina Groti | |
| dc.contributor.author | Tenover, Joyce Lisa | |
| dc.contributor.author | Tan, Hui Meng | |
| dc.contributor.author | Ho Chee Kong, Christopher | |
| dc.contributor.author | Tan, Wei Shen | |
| dc.contributor.author | Marks, Leonard S | |
| dc.contributor.author | Ross, Richard J | |
| dc.contributor.author | Schwartz, Robert S | |
| dc.contributor.author | Manson, Paul | |
| dc.contributor.author | Roberts, Stephen A | |
| dc.contributor.author | Skovsager Andersen, Marianne | |
| dc.contributor.author | Velling Magnussen, Line | |
| dc.contributor.author | Aceves-Martins, Magaly | |
| dc.contributor.author | Gillies, Katie | |
| dc.contributor.author | Hernández, Rodolfo | |
| dc.contributor.author | Oliver, Nick | |
| dc.contributor.author | Dhillo, Waljit S | |
| dc.contributor.author | Bhattacharya, Siladitya | |
| dc.contributor.author | Brazzelli, Miriam | |
| dc.contributor.author | Jayasena, Channa N | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.contributor.institution | University of Aberdeen.Centre for Healthcare Randomised Trials (CHaRT) | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Rowett Institute | en |
| dc.contributor.institution | University of Aberdeen.Health Economics Research Unit | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.M&D School Administration | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Women’s Health Research | en |
| dc.date.accessioned | 2023-10-05T13:22:00Z | |
| dc.date.available | 2023-10-05T13:22:00Z | |
| dc.date.issued | 2023-10-04 | |
| dc.description | Acknowledgments This work was supported by the UK National Institute for Health and Care Research (NIHR)'s Health Technology Assessment Programme (project number 17/68/01). The views expressed herein are those of the authors and not necessarily those of the National Health Service, the NIHR Health Technology Assessment Programme, or the UK Department of Health and Social Care. The Health Services Research Unit at the University of Aberdeen is funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. The Section of Endocrinology and Investigative Medicine at Imperial College London is funded by grants from the Medical Research Council, the Biotechnology and Biological Sciences Research Council, NIHR, an Integrative Mammalian Biology Capacity Building Award, and an FP7-HEALTH-2009-241592 EuroCHIP grant, and is supported by the NIHR Biomedical Research Centre Funding Scheme. WSD is funded by an NIHR Research Professorship. CNJ is funded by an NIHR Post-Doctoral Fellowship. ShB receives NIH research grant funding. The authors are grateful to the clinical and methodological experts and patient partners who contributed to the advisory group for this study. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 11 | |
| dc.format.extent | 1827913 | |
| dc.identifier | 281687194 | |
| dc.identifier | 7a793571-0710-4144-b9b5-e11de6e4a428 | |
| dc.identifier | 85172893601 | |
| dc.identifier | 37804846 | |
| dc.identifier.citation | Hudson, J, Cruickshank, M, Quinton, R, Aucott, L, Wu, F, Grossmann, M, Bhasin, S, Snyder, P J, Ellenberg, S S, Travison, T G, Brock, G B, Gianatti, E J, van der Schouw, Y T, Emmelot-Vonk, M H, Giltay, E J, Hackett, G, Ramachandran, S, Svartberg, J, Hildreth, K L, Antonic, K G, Tenover, J L, Tan, H M, Ho Chee Kong, C, Tan, W S, Marks, L S, Ross, R J, Schwartz, R S, Manson, P, Roberts, S A, Skovsager Andersen, M, Velling Magnussen, L, Aceves-Martins, M, Gillies, K, Hernández, R, Oliver, N, Dhillo, W S, Bhattacharya, S, Brazzelli, M & Jayasena, C N 2023, 'Symptomatic benefits of testosterone treatment in patient subgroups : a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis', The Lancet Healthy Longevity, vol. 4, no. 10, pp. e561-e572. https://doi.org/10.1016/S2666-7568 | en |
| dc.identifier.doi | 10.1016/S2666-7568 | |
| dc.identifier.iss | 10 | en |
| dc.identifier.issn | 2666-7568 | |
| dc.identifier.other | RIS: urn:2CB07A610870E6B5BAA30AD5ADF158C6 | |
| dc.identifier.other | ORCID: /0000-0001-7890-2854/work/144003465 | |
| dc.identifier.other | ORCID: /0000-0002-5182-884X/work/144003710 | |
| dc.identifier.other | ORCID: /0000-0002-9441-142X/work/144003883 | |
| dc.identifier.other | ORCID: /0000-0001-6277-7972/work/144003890 | |
| dc.identifier.other | ORCID: /0000-0002-4588-356X/work/159509858 | |
| dc.identifier.other | ORCID: /0000-0003-2619-8230/work/162727160 | |
| dc.identifier.uri | https://hdl.handle.net/2164/21848 | |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S2666756823001691 | en |
| dc.identifier.vol | 4 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | The Lancet Healthy Longevity | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Hydraulic fracturing | en |
| dc.subject | Natural fracture | en |
| dc.subject | In-situ stresses | en |
| dc.subject | Well orientation | en |
| dc.subject | R Medicine | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject | Supplementary Data | en |
| dc.subject | 17/68/01 | en |
| dc.subject.lcc | R | en |
| dc.title | Symptomatic benefits of testosterone treatment in patient subgroups : a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Hudson_etal_LHL_Symtomatic_Benefits_Of_VOR.pdf
- Size:
- 1.74 MB
- Format:
- Adobe Portable Document Format
